Stocks Near Their 52-Week High · Pharmaceutical Preparations
31 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — momentum/breakout candidates, largest first. Filtered to Pharmaceutical Preparations. Data as of close · Checked
| LLY | Lilly (Eli) | 0.30 | 44.73 | +10.69% | +17.02% | +28.67% | Golden | 75.73 | 82.8% | Bullish | Bullish | -2.66% | +65.71% | -0.93% | Head and Shoulders | — | 1409.39 | -0.12% |
| JNJ | Johnson & Johnson | -0.20 | 6.54 | +1.42% | +0.24% | +7.53% | Golden | 51.47 | 48.1% | Bullish | Strongly Bullish | -5.61% | +43.68% | -0.77% | Channel Down | — | 266.17 | -1.76% |
| ONC | Beone Medicines Ltd. | 0.66 | 10.22 | -3.20% | -2.12% | +9.16% | Golden | 42.20 | 17.3% | Bearish | Neutral | -8.65% | +39.75% | -2.80% | Double Bottom | — | 354.91 | -1.72% |
| ABBV | AbbVie | -0.16 | 6.85 | +0.44% | +5.48% | +19.86% | Golden | 56.31 | 33.6% | Bearish | Bullish | -4.55% | +49.42% | -0.07% | Channel Up | — | 285.02 | -1.30% |
| MRK | Merck | 0.01 | 4.36 | -0.44% | -1.40% | +13.82% | Golden | 48.67 | 36.0% | Bullish | Bullish | -7.80% | +76.36% | -0.99% | Double Top | — | 144.67 | -2.57% |
| PFE | Pfizer | 0.19 | 0.62 | +1.96% | +4.89% | +11.92% | Golden | 58.55 | 44.9% | Bullish | Strongly Bullish | -3.22% | +27.18% | +0.41% | Double Bottom | Bearish Engulfing | 30.04 | -2.18% |
| VRTX | Vertex Pharmaceuticals | 0.41 | 18.97 | +2.27% | +1.49% | +10.56% | Golden | 52.39 | 38.3% | Bullish | Strongly Bullish | -9.21% | +31.31% | -1.58% | Channel Down | Bearish Marubozu | 531.19 | -6.81% |
| REGN | Regeneron Pharmaceuticals | 0.26 | 27.48 | +19.84% | +21.90% | +31.62% | Golden | 82.57 | 99.3% | Bullish | Bullish | -0.14% | +64.59% | -0.34% | Channel Down | — | 973.80 | +1.30% |
| TEVA | Teva Pharmaceutical Industries Ltd | 0.69 | 1.29 | +2.94% | +6.78% | +20.86% | Golden | 59.45 | 66.1% | Bullish | Strongly Bullish | -3.30% | +108.35% | +3.01% | — | Doji | 41.90 | +3.00% |
| RPRX | Royalty Pharma Plc | 0.13 | 1.60 | +7.28% | +9.70% | +24.04% | Golden | 71.06 | 83.4% | Bullish | Bullish | -2.00% | +84.31% | +0.71% | Descending Triangle | — | 66.35 | -0.26% |
| UTHR | United Therapeutics Corp | 0.20 | 15.56 | +6.23% | +13.43% | +12.93% | Death | 70.27 | 91.2% | Bullish | Bullish | -1.21% | +39.90% | +0.40% | Channel Up | — | 601.74 | +0.95% |
| VTRS | Viatris | 0.67 | 0.46 | +3.71% | +7.91% | +18.70% | Golden | 60.73 | 68.9% | Bullish | Strongly Bullish | -2.87% | +90.93% | +0.05% | Channel Up | — | 18.94 | +1.39% |
| SYRE | Spyre Therapeutics, Inc. | 1.68 | 4.75 | +11.30% | +11.05% | +34.61% | Golden | 62.05 | 94.4% | Bullish | Strongly Bullish | -9.87% | +396.65% | -0.53% | — | Bullish Engulfing | 99.33 | +3.99% |
| TGTX | Tg Therapeutics, Inc. | 0.33 | 2.56 | +9.23% | +9.43% | +37.79% | Golden | 66.03 | 80.1% | Bullish | Strongly Bullish | -4.41% | +127.11% | +0.80% | — | Spinning Top | 60.77 | +1.27% |
| KNSA | Kiniksa Pharmaceuticals International, Plc | 0.53 | 4.54 | +12.09% | +16.93% | +53.36% | Golden | 62.99 | 81.2% | Bullish | Strongly Bullish | -5.29% | +154.44% | +1.21% | — | — | 93.15 | +2.69% |
| LGND | Ligand Pharmaceuticals Inc | 0.77 | 12.13 | +2.52% | +5.54% | +23.72% | Golden | 55.04 | 67.8% | Bullish | Strongly Bullish | -4.56% | +78.52% | +1.36% | — | — | 314.00 | +2.41% |
| ARQT | Arcutis Biotherapeutics, Inc. | 1.11 | 1.35 | +8.12% | +19.01% | +26.50% | Golden | 62.89 | 82.9% | Bullish | Strongly Bullish | -3.84% | +65.91% | +1.73% | — | Spinning Top | 32.02 | +2.46% |
| OGN | Organon & Co. | 0.87 | 0.04 | +0.52% | +0.75% | +19.66% | Golden | 65.80 | 96.2% | Bullish | Strongly Bullish | -0.04% | +143.32% | +0.04% | — | — | 13.85 | +0.18% |
| SLN | Silence Therapeutics Plc | 1.54 | 0.69 | +27.15% | +44.27% | +115.15% | Golden | 78.65 | 98.7% | Bullish | Bullish | -4.72% | +374.58% | +0.10% | — | Spinning Top | 19.79 | +0.13% |
| PVLA | Palvella Therapeutics, Inc. | 1.60 | 8.59 | +14.73% | +7.89% | +20.01% | Golden | 64.70 | 91.6% | Bullish | Strongly Bullish | -4.94% | +113.21% | -0.65% | Channel Down | Bullish Engulfing | 153.00 | +4.39% |
| ZYME | Zymeworks Inc. | 0.61 | 1.47 | +10.89% | +10.21% | +19.16% | Golden | 67.82 | 95.4% | Bullish | Strongly Bullish | -3.44% | +86.33% | -1.76% | Symmetrical Triangle | — | 30.13 | +3.90% |
| XERS | Xeris Biopharma Holdings, Inc. | 0.76 | 0.68 | -0.76% | +10.53% | +37.63% | Golden | 53.63 | 52.2% | Bearish | Bullish | -9.24% | +102.74% | -0.49% | — | — | 10.36 | +2.07% |
| PCRX | Pacira Biosciences, Inc. | 0.17 | 0.52 | +1.60% | +23.22% | +45.57% | Golden | 83.00 | 55.1% | Bearish | Bullish | -0.84% | +102.28% | -0.03% | Channel Up | Gravestone Doji | 36.39 | -0.03% |
| OPK | OPKO HEALTH, INC. | 0.97 | 0.08 | +10.92% | +9.88% | +28.17% | Golden | 62.23 | 66.7% | Bullish | Strongly Bullish | -7.49% | +76.55% | +1.16% | — | Spinning Top | 1.73 | +0.00% |
| AMPH | Amphastar Pharmaceuticals, Inc. | 0.50 | 0.95 | +3.37% | +8.56% | +21.84% | Golden | 60.56 | 82.5% | Bullish | Strongly Bullish | -8.08% | +69.56% | -0.11% | — | Spinning Top | 27.13 | +0.11% |
| RIGL | Rigel Pharmaceuticals Inc | 0.83 | 1.75 | +0.22% | +2.22% | +31.25% | Golden | 51.16 | 48.8% | Bullish | Strongly Bullish | -6.52% | +95.99% | +0.27% | Double Top | — | 48.92 | -3.09% |
| DMAC | DiaMedica Therapeutics Inc. | 1.55 | 0.51 | +16.72% | +29.44% | +40.61% | Golden | 70.09 | 98.8% | Bullish | Bullish | -8.91% | +104.07% | +0.91% | Channel Up | Bullish Marubozu | 10.02 | +7.63% |
| RLYB | Rallybio Corp | 0.60 | 0.32 | -3.74% | -5.13% | +24.82% | Golden | 35.81 | 26.0% | Bearish | Bearish | -9.31% | +315.58% | +1.14% | — | Inverted Hammer | 15.88 | +0.67% |
| TAK | Takeda Pharmaceutical Co Ltd | 0.04 | 0.39 | +5.18% | +9.55% | +17.96% | Golden | 68.36 | 74.0% | Bullish | Strongly Bullish | -2.17% | +55.51% | +0.53% | — | — | 20.76 | -0.57% |
| NVS | Novartis Ag | 0.31 | 3.13 | +4.81% | +7.37% | +4.80% | Death | 64.08 | 67.6% | Bullish | Bullish | -6.56% | +29.60% | -0.17% | Symmetrical Triangle | — | 159.23 | -1.38% |
| GMAB | Genmab A/S | 0.74 | 2.38 | +27.93% | +45.97% | +80.58% | Golden | 78.39 | 80.7% | Bullish | Bullish | -7.45% | +134.93% | +1.04% | — | Doji | 55.49 | +1.02% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.